Pharmaceutical studies of Amphotericin-B : oral formulation using nanotechnology

Amphotericin B (AmB) is the gold standard treatment of systemic fungal infections. It is the secondary treatment of leishmaniasis with 97% cure rate with no reported resistance. However, the only dosage form of AmB in the market is parenteral formulations as intermittent iv infusion. Sodium deoxycho...

Full description

Bibliographic Details
Main Author: Al Quadeib, Bushra
Published: University of Newcastle upon Tyne 2016
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.697886

Similar Items